MOGGI PIGNONE, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.090
EU - Europa 3.378
AS - Asia 823
AF - Africa 11
SA - Sud America 6
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.313
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.070
PL - Polonia 818
IE - Irlanda 738
IT - Italia 588
SE - Svezia 554
HK - Hong Kong 357
CN - Cina 183
UA - Ucraina 160
FI - Finlandia 146
DE - Germania 143
GB - Regno Unito 95
JO - Giordania 83
TR - Turchia 78
RU - Federazione Russa 58
VN - Vietnam 43
IN - India 38
SG - Singapore 22
CA - Canada 20
CH - Svizzera 20
FR - Francia 14
ES - Italia 12
BE - Belgio 8
NL - Olanda 8
BR - Brasile 6
JP - Giappone 6
TH - Thailandia 6
CM - Camerun 5
SC - Seychelles 5
AT - Austria 4
AU - Australia 3
HU - Ungheria 3
HR - Croazia 2
IL - Israele 2
KR - Corea 2
PT - Portogallo 2
RO - Romania 2
TW - Taiwan 2
EU - Europa 1
GR - Grecia 1
IQ - Iraq 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
Totale 11.313
Salva come PNG Salva come JPEG
Città #
Fairfield 1.117
Warsaw 818
Chandler 804
Dublin 731
Ashburn 591
Woodbridge 493
Cambridge 439
Seattle 436
Wilmington 369
Houston 356
Jacksonville 268
Princeton 198
Hong Kong 195
Ann Arbor 181
Lawrence 168
Altamura 167
Florence 161
Boardman 120
Boston 115
Medford 113
Beijing 108
Buffalo 93
San Diego 75
Izmir 67
Moscow 46
Falls Church 40
Dong Ket 39
Shanghai 34
Norwalk 33
New York 28
Pune 24
Andover 21
Hillsboro 21
Milan 21
Singapore 20
Bern 13
Toronto 13
West Jordan 12
Dearborn 11
Rome 11
Bremen 9
London 9
Brussels 8
Frankfurt Am Main 8
Los Angeles 8
Lucca 8
Redwood City 8
Auburn Hills 6
Barcelona 6
Guangzhou 6
Kent 6
Salerno 6
Verona 6
Philadelphia 5
Redmond 5
Tappahannock 5
Turin 5
Basel 4
Chiang Mai 4
Chicago 4
Erzurum 4
Hangzhou 4
Hounslow 4
Shenzhen 4
Vienna 4
Bom Jardim 3
Budapest 3
Campi Bisenzio 3
Catania 3
Chengdu 3
Chiswick 3
Laurel 3
Nanjing 3
Old Bridge 3
Phoenix 3
Pittsburgh 3
Prato 3
San Jose 3
San Mateo 3
Tokyo 3
Acton 2
Bangkok 2
Barletta 2
Bergamo 2
Brooklyn 2
Cagliari 2
Campinas 2
Caserta 2
Central 2
Dallas 2
Domodossola 2
Düsseldorf 2
Gainesville 2
Gragnano 2
Hamburg 2
Hefei 2
Ho Chi Minh City 2
Kilburn 2
La Jolla 2
Langen 2
Totale 8.801
Salva come PNG Salva come JPEG
Nome #
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis 217
[Peripheral nervous system in limited systemic sclerosis]. 208
Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. 191
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 190
Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit 147
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 122
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 117
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 116
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 115
Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system 115
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 111
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 104
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 103
Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura 100
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 100
The platypnea-orthodeoxia syndrome: an unusual case of dyspnea 99
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis 95
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 94
The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in Internal Medicine 93
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 92
A rare case of Candida glabrata spondylodiscitis: case report and literature review 91
Cardiac amyloidosis: the heart of the matter. 91
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 88
The safety of iloprost in systemic sclerosis in a real-life experience 88
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers 87
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. 86
Oxidative stress in Systemic Sclerosis. 83
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. 83
Therapeutic challenges for systemic sclerosis: facts and future targets. 82
Etrurians vs Greeks: May ACE I/D polymorphism still be considered as a marker of susceptibility to SSc? 82
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 81
Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study. 80
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 80
Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach. 79
Letter to Habets JGV et al. on “A rare case of Candida glabrata spondylodiscitis: case report and literature review” 79
Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment. 78
Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. 78
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. 78
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting 78
Valutazione circadiana dell’ attività fibrinolitica circolante nella Sclerosi Sistemica. 78
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 77
The autonomic nervous system in systemic sclerosis. A review 77
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 77
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 77
Dimensions of psychological dysfunction in patients with fibromyalgia: development of an Italian questionnaire. 76
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. 76
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) 76
Therapeutic challenges for systemic sclerosis: facts and future targets. 75
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 75
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 74
Resistance to Apoptosis in Circulating a/ss and γ⁄δ T Lymphocytes from Patients with Systemic Sclerosis. 74
Systemic amyloidosis: a challenge for the rheumatologist. 73
The renal resistive index, a new biomarker for the follow up of vascular modifications in Systemic Sclerosis 73
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 72
Central nervous system hemangiopericytoma with bone and lung metastases: a case report. 71
Seasonal pattern in the onset of polymyalgia rheumatica. 71
High resolution computed tomography in systemic sclerosis. Real diagnostic utilities in the assessment of pulmonary involvement and comparison with other modalities of lung investigation. 70
Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without evidence of atrial fibrillation. 70
Angiotensin converting enzyme a new tool for the follow-up of endothelial injury in paediatric vasculitides. 69
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 68
Are disease-related pulmonary perfusion abnormalities detectable in COVID-19 patients? Suspicious findings in a lung perfusion SPECT performed for ruling out classical pulmonary embolism 68
LUNG ULTRASOUND FOR THE SCREENING OF INTERSTITIAL LUNG DISEASE IN VERY EARLY SYSTEMIC SCLEROSIS 68
Blood coagulation , fibrinolysis and markers of endothelial dysfunction in systemic sclerosis. 68
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis. 67
Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis. 66
A case of persistent hiccup after laparoscopic cholecystectomy. 66
Early detection of myocardial and pulmonary oedema with MRI in an asymptomatic systemic sclerosis patient: successful recovery with pulse steroid. 66
Cardiac amyloidosis: the heart of the matter. 65
Amyloidoses 65
Acute heart failure in the elderly: setting related differences in clinical features and management 65
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 65
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? 64
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. 63
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement. 62
Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study. 62
null 61
Tako-tsubo-like syndrome in systemic sclerosis: a sign of myocardial Raynaud phenomenon? 60
Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. 60
Tako-Tsubo like syndrome in systemic sclerosis: a sign of myocardial Raynaud Phenomenon? 60
Markers of disease activity in systemic sclerosis. 59
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. 59
Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus. 58
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. 58
Collagenase synthesis of rheumatoid arthritis synoviocytes: dose-dependent stimulation by substance P and capsaicin. 58
Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists 58
Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface. 57
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 57
Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis. 56
Current Treatment Options in Raynaud's Phenomenon. 56
Chronobiology, fibrinolysis, and systemic sclerosis. 56
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 56
RALOXIFENE (RAL) MODULA IL PROFILO FIBRINOLITICO E RIDUCE CHEMIOINVASIONE E PROLIFERAZIONE NEI SINOVIOCITI (SI) REUMATOIDI (AR) BLOCCANDO L'INTERAZIONE U-PA/U-PAR E RIDUCENDO LA PRODUZIONE DI U-PA. REUMATISMO, 2004 VOL 56 N°3 (NUMERO SPECIALE 3) 56
Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: a longitudinal study of plasma ACE level, endothelial injury and lung involvement. 56
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis 55
Fibrinolytic activity in the synovial membrane of osteoarthritis. 55
[The treatment of skin ulcers in patients with systemic sclerosis]. 55
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis 55
Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis. 54
The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy). 54
Right ventricular function in AL amyloidosis: characteristics and prognostic implication. 54
Totale 8.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019740 0 0 0 0 0 0 0 0 0 0 426 314
2019/20202.317 177 179 64 183 247 295 258 292 242 148 168 64
2020/20211.716 127 89 93 290 114 183 78 131 159 215 113 124
2021/20221.285 51 107 53 68 67 121 46 69 62 65 200 376
2022/20233.142 342 555 121 266 249 588 404 160 299 27 89 42
2023/20241.200 67 140 205 57 85 208 71 242 27 92 6 0
Totale 11.486